The effect of pyrimidine compounds on the potentiation of adenosine inhibition of aggregation, on adenosine phosphorylation and phosphodiesterase activity of blood platelets.
D000241:Adenosine / Q000378:metabolism; D000244:Adenosine Diphosphate / Q000494:pharmacology*; D000249:Adenosine Monophosphate / Q000378:metabolism; D001792:Blood Platelets / Q000201:enzymology / Q000378:metabolism*; D002247:Carbon Isotopes; D000242:Cyclic AMP / Q000378:metabolism; D004176:Dipyridamole / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005021:Ethylamines / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D009025:Morpholines / Q000494:pharmacology; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D010880:Piperidines / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011743:Pyrimidines / Q000494:pharmacology*; D013876:Thiophenes / Q000494:pharmacology
D002247:Carbon Isotopes; D004983:Ethanolamines; D005021:Ethylamines; D009025:Morpholines; D010880:Piperidines; D011743:Pyrimidines; D013876:Thiophenes; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D000241:Adenosine